Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. EFFEXOR XR® (venlafaxine HCl) is not approved for use in children and teens.
Your guide has 0 topics.
No topics to add
See your guide
Close
Fill in the information below to send an e-mail message and a link to this page.
Recipient's e-mail address
Your e-mail address
Send
This form does not collect your information. To learn more about our use of your information and your rights, please consult our Privacy Policy.
A message has been sent to your intended recipient with a link to this page. He or she will receive it shortly.
Thank you.